![Inge Lues](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Inge Lues worked as Vice President-Global Drug Discovery at Merck KGaA in 2007.
From 2008 to 2018, Lues worked at Vivoryon Therapeutics NV, where she held the position of Chief Development Officer from 2013 to 2018.
Tidigare kända positioner av Inge Lues
| Företag | Position | Slut |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Teknisk/Vetenskaplig/F&U Direktör | 2018-10-31 |
| MERCK KGAA | Företagsledare/Principal | 2007-01-01 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
11
Första gradens relationer
2
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 2 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
